9. Pharmacologic Approaches to Glycemic Treatment: <i>Standards of Medical Care in Diabetes—2022</i>

2021 Diabetes Care 1,505 citations

Abstract

The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc22-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc22-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.

MeSH Terms

Blood GlucoseDiabetes MellitusEndocrinologyHumansReference StandardsSocietiesMedicalStandard of Care

Related Publications

Publication Info

Year
2021
Type
article
Volume
45
Issue
Supplement_1
Pages
S125-S143
Citations
1505
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

1505
OpenAlex
22
Influential
656
CrossRef

Cite This

(2021). 9. Pharmacologic Approaches to Glycemic Treatment: <i>Standards of Medical Care in Diabetes—2022</i>. Diabetes Care , 45 (Supplement_1) , S125-S143. https://doi.org/10.2337/dc22-s009

Identifiers

DOI
10.2337/dc22-s009
PMID
34964831

Data Quality

Data completeness: 72%